RenovoRx Inc Forecast, price target & analysts
RenovoRx Inc Target price 2025 - Analyst rating & recommendation
RenovoRx Inc Classifications & Recommendation:
RenovoRx Inc Price Target
| Target Price | $3.83 |
| Price | $1.18 |
| Potential |
224.15%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target RenovoRx Inc 2026 .
The average RenovoRx Inc target price is $3.83.
This is
224.15%
register free of charge
$12.60
967.80%
register free of charge
$3.03
156.78%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend RenovoRx Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the RenovoRx Inc stock has an average upside potential 2026 of
224.15%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 0.04 | 1.29 |
| 3,120.00% | ||
| Net Margin | -22,025.00% | -950.54% |
| 95.68% |
6 Analysts have issued a sales forecast RenovoRx Inc 2025 . The average RenovoRx Inc sales estimate is
This results in the following potential growth metrics:
6 RenovoRx Inc Analysts have issued a net profit forecast 2025. The average RenovoRx Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.40 | -0.33 |
| 59.60% | 17.50% | |
| P/E | negative | |
| EV/Sales | 24.01 |
6 Analysts have issued a RenovoRx Inc forecast for earnings per share. The average RenovoRx Inc EPS is
This results in the following potential growth metrics and future valuations:
Current RenovoRx Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Aug 25 2025 |
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Jun 05 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 19 2025 |
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Apr 28 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 04 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 27 2025 |
| Ascendiant Capital |
Locked
➜
Locked
|
Locked | Dec 10 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Aug 25 2025 |
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Jun 05 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 19 2025 |
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Apr 28 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 04 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 27 2025 |
|
Locked
Ascendiant Capital:
Locked
➜
Locked
|
Dec 10 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
